Gen Consulting Company predicts global transfection reagents and equipment market will grow from USD 1,003 million in 2021 to USD 1,752 million by 2028, achieving a CAGR of 8.5 percent, according to the latest edition of the Global Transfection Reagents and Equipment Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global transfection reagents and equipment market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the transfection reagents and equipment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, method, application, and region. The global market for transfection reagents and equipment can be segmented by product: reagent, equipment. In 2021, the reagent segment made up the largest share of revenue generated by the transfection reagents and equipment market. Transfection reagents and equipment market is further segmented by method: electroporation, liposomes, particle bombardment, microinjection, adenoviral vectors, microinjection, calcium phosphate, diethylaminoethyl (DEAE)-dextran, magnetic beads, activated dendrimers, laserfection. The electroporation segment was the largest contributor to the global transfection reagents and equipment market in 2021. Based on application, the transfection reagents and equipment market is segmented into: gene expression study, protein production, transgenic models, therapeutic delivery, cancer research, biomedical research, others. The gene expression study segment is estimated to account for the largest share of the global transfection reagents and equipment market. On the basis of region, the transfection reagents and equipment market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global transfection reagents and equipment market in 2021 and is anticipated to hold its share during the forecast period.

Market Segmentation
By product: reagent, equipment
By method: electroporation, liposomes, particle bombardment, microinjection, adenoviral vectors, microinjection, calcium phosphate, diethylaminoethyl (DEAE)-dextran, magnetic beads, activated dendrimers, laserfection
By application: gene expression study, protein production, transgenic models, therapeutic delivery, cancer research, biomedical research, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte, Inc., Merck KGaA, OriGene Technologies, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen N.V., Roche Holding AG, Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global transfection reagents and equipment market.
– To classify and forecast the global transfection reagents and equipment market based on product, method, application, region.
– To identify drivers and challenges for the global transfection reagents and equipment market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global transfection reagents and equipment market.
– To identify and analyze the profile of leading players operating in the global transfection reagents and equipment market.

Why Choose This Report
– Gain a reliable outlook of the global transfection reagents and equipment market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.